Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave

Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave

Submitted by admin on March 8, 2019 - 10:04am
Source: 
Xconomy
News Tags: 
Acorda Therapeutics
Parkinson's Disease
Andrew Hindman
Inbrija
Headline: 
Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave
snippet: 

Acorda Therapeutics (NASDAQ: ACOR), which has just launched a new Parkinson’s disease treatment, is saying farewell to chief business officer Andrew Hindman. 

Do Not Allow Advertisers to Use My Personal information